chr22-50517802-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152299.4(NCAPH2):c.413C>T(p.Thr138Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,613,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152299.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NCAPH2 | NM_152299.4 | c.413C>T | p.Thr138Met | missense_variant | 5/20 | ENST00000420993.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NCAPH2 | ENST00000420993.7 | c.413C>T | p.Thr138Met | missense_variant | 5/20 | 1 | NM_152299.4 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000722 AC: 11AN: 152252Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000723 AC: 18AN: 249116Hom.: 0 AF XY: 0.0000593 AC XY: 8AN XY: 134878
GnomAD4 exome AF: 0.0000363 AC: 53AN: 1461514Hom.: 0 Cov.: 33 AF XY: 0.0000344 AC XY: 25AN XY: 727018
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152370Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74510
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 15, 2023 | The c.413C>T (p.T138M) alteration is located in exon 5 (coding exon 5) of the NCAPH2 gene. This alteration results from a C to T substitution at nucleotide position 413, causing the threonine (T) at amino acid position 138 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at